chr10-103882691-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024928.5(STN1):c.1100C>T(p.Ala367Val) variant causes a missense change. The variant allele was found at a frequency of 0.000505 in 1,610,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A367A) has been classified as Likely benign.
Frequency
Consequence
NM_024928.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STN1 | NM_024928.5 | c.1100C>T | p.Ala367Val | missense_variant | 10/10 | ENST00000224950.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STN1 | ENST00000224950.8 | c.1100C>T | p.Ala367Val | missense_variant | 10/10 | 1 | NM_024928.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000402 AC: 100AN: 248560Hom.: 0 AF XY: 0.000477 AC XY: 64AN XY: 134266
GnomAD4 exome AF: 0.000520 AC: 758AN: 1458128Hom.: 0 Cov.: 30 AF XY: 0.000495 AC XY: 359AN XY: 725090
GnomAD4 genome AF: 0.000361 AC: 55AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74372
ClinVar
Submissions by phenotype
Cerebroretinal microangiopathy with calcifications and cysts 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 30, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.1100C>T (p.A367V) alteration is located in exon 10 (coding exon 9) of the OBFC1 gene. This alteration results from a C to T substitution at nucleotide position 1100, causing the alanine (A) at amino acid position 367 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 17, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 367 of the STN1 protein (p.Ala367Val). This variant is present in population databases (rs140449924, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with STN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1028354). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at